Get notified when PRME files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: PRME Prime Medicine, Inc. 8-K

Prime Medicine reports Q1 2026 financial results and business highlights

Filed May 7, 2026 · Period ending May 7, 2026 · ~1 min read

Key Changes

  • high

    Prime Medicine issued a press release announcing its financial results and business highlights for the quarter ended March 31, 2026. The 8-K filing itself does not contain specific financial figures or operational updates.

    Item 2.02 verify on EDGAR →
  • high

    The complete financial results and business updates are provided in the attached press release (Exhibit 99.1), which investors should review directly for details on revenue, expenses, cash position, and pipeline progress.

    Exhibit 99.1 view on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (THRM 10-Q) is open in full — no account needed.

Partner

Trade PRME commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov Press release (Ex 99.1) on EDGAR ↗

Source-verified from EDGAR · Narrative written by AI · Jun 9, 2026 · How we verify